Blood flow-dependent uptake of indium-111 monoclonal antimyosin antibody in canine acute myocardial infarction
- PMID: 7678020
- DOI: 10.1016/0735-1097(93)90742-j
Blood flow-dependent uptake of indium-111 monoclonal antimyosin antibody in canine acute myocardial infarction
Abstract
Objectives: The relation of myocardial blood flow and indium-111 (111In) antimyosin antibody uptake was studied by inducing myocardial infarction in 18 dogs, 8 with closed chest left anterior descending artery balloon occlusion for 3 h followed by reperfusion (group A) and 10 dogs with open chest left anterior descending artery ligation (without reperfusion, group B).
Background: The relation of antimyosin uptake to myocardial injury has been documented. However, its relation to tracer delivery by myocardial blood flow has not been studied and has been assumed to be independent.
Methods: Indium-111 antimyosin antibody, 2 mCi, was injected 20 min after reperfusion and 3 h after coronary artery ligation in groups A and B, respectively. Regional blood flows were determined by radiolabeled microspheres during occlusion and 24 h later in both groups. On day 2, dogs were killed after risk zone delineation with gentian violet. The heart was excised and stained with triphenyltetrazolium chloride solution and graded for increasing severity of tissue injury based on extent of staining. Microsphere activity and 111In antimyosin activity were measured in control tissue (grade 1), noninfarct tissue at risk (grade 2), mixed tissue (grade 3), infarct tissue (grade 4) and hemorrhagic infarct tissue (grade 5, present only in group A dogs). Count activity was normalized to that of the mean value in control tissue (grade 1) and expressed as a ratio of activity.
Results: Indium-111 antimyosin activity was high in triphenyltetrazolium chloride grade 4 tissue in both groups but was attenuated in grade 4 tissue in group B dogs (10.6 +/- 5.1 vs. 5.0 +/- 4.5; p < 0.05 group A vs. group B), which had lower blood flow on day 2 (0.51 +/- 0.36 vs. 0.23 vs. 0.22; p < 0.01). Normalizing 111In antimyosin activity for blood flow on day 2 resulted in equivalent 111In antimyosin uptake for infarct tissue (32.6 +/- 21.6 vs. 36.6 +/- 29.8 for group A vs. group B; p = NS).
Conclusions: Thus, 111In antimyosin uptake is a specific marker of necrotic tissue with a high signal ratio in reperfused tissue. However, its uptake is dependent on residual blood flow in the infarct territory. Indium-111 antimyosin could potentially serve as a suitable tracer for infarct sizing if myocardial blood flow in the same region were factored simultaneously.
Similar articles
-
Effect of reperfusion on 111In-antimyosin monoclonal antibody uptake by salvaged and necrotic myocardium in the dog.Cardiovasc Res. 1993 Aug;27(8):1504-9. doi: 10.1093/cvr/27.8.1504. Cardiovasc Res. 1993. PMID: 8221805
-
Evaluation of myocardial infarct size before and after reperfusion: dual-tracer imaging with radiolabeled antimyosin antibody.J Nucl Med. 1994 Jun;35(6):1076-85. J Nucl Med. 1994. PMID: 8195873
-
Indium-111-antimyosin images compared with triphenyl tetrazolium chloride staining in a patient six days after myocardial infarction.J Nucl Med. 1990 Feb;31(2):231-3. J Nucl Med. 1990. PMID: 1690274
-
[Indium III monoclonal antimyosin antibody scintigraphy for the detection of chronic myocardial infarction apart from the acute phase].Arch Mal Coeur Vaiss. 1995 Dec;88(12):1863-8. Arch Mal Coeur Vaiss. 1995. PMID: 8729367 Review. French.
-
The role of antimyosin antibodies in acute myocardial infarction.Semin Nucl Med. 1989 Jul;19(3):238-46. doi: 10.1016/s0001-2998(89)80016-9. Semin Nucl Med. 1989. PMID: 2669131 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous